ANGEL STUDIOS INC (ANGX) Fundamental Analysis & Valuation

NYSE:ANGX • US0349481095

Current stock price

2.6229 USD
+0.1 (+4.08%)
Last:

This ANGX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ANGX Profitability Analysis

1.1 Basic Checks

  • ANGX had negative earnings in the past year.
  • ANGX had a negative operating cash flow in the past year.
ANGX Yearly Net Income VS EBIT VS OCF VS FCFANGX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 -50M -100M -150M

1.2 Ratios

  • With a Return On Assets value of -70.62%, ANGX is not doing good in the industry: 88.61% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -70.62%
ROE N/A
ROIC N/A
ROA(3y)-45.42%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ANGX Yearly ROA, ROE, ROICANGX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 500 -500 -1K

1.3 Margins

  • ANGX's Gross Margin of 61.17% is fine compared to the rest of the industry. ANGX outperforms 69.62% of its industry peers.
  • In the last couple of years the Gross Margin of ANGX has grown nicely.
  • ANGX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.56%
GM growth 5YN/A
ANGX Yearly Profit, Operating, Gross MarginsANGX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 50 -50

0

2. ANGX Health Analysis

2.1 Basic Checks

  • ANGX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ANGX has more shares outstanding
  • ANGX has a worse debt/assets ratio than last year.
ANGX Yearly Shares OutstandingANGX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 50M 100M 150M
ANGX Yearly Total Debt VS Total AssetsANGX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -1.58, we must say that ANGX is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ANGX (-1.58) is worse than 70.89% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.58
ROIC/WACCN/A
WACC9.52%
ANGX Yearly LT Debt VS Equity VS FCFANGX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • ANGX has a Current Ratio of 0.62. This is a bad value and indicates that ANGX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ANGX's Current ratio of 0.62 is on the low side compared to the rest of the industry. ANGX is outperformed by 70.89% of its industry peers.
  • ANGX has a Quick Ratio of 0.62. This is a bad value and indicates that ANGX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.61, ANGX is doing worse than 70.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.62
Quick Ratio 0.61
ANGX Yearly Current Assets VS Current LiabilitesANGX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 50M 100M 150M 200M

7

3. ANGX Growth Analysis

3.1 Past

  • ANGX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -71.66%.
  • ANGX shows a strong growth in Revenue. In the last year, the Revenue has grown by 233.16%.
  • Measured over the past years, ANGX shows a very strong growth in Revenue. The Revenue has been growing by 62.08% on average per year.
EPS 1Y (TTM)-71.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.58%
Revenue 1Y (TTM)233.16%
Revenue growth 3Y62.08%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 22.64% on average over the next years. This is a very strong growth
  • ANGX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 35.80% yearly.
EPS Next Y72.4%
EPS Next 2Y35.16%
EPS Next 3Y22.64%
EPS Next 5YN/A
Revenue Next Year50.47%
Revenue Next 2Y37.59%
Revenue Next 3Y35.8%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ANGX Yearly Revenue VS EstimatesANGX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
ANGX Yearly EPS VS EstimatesANGX Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 -0.5 -1 -1.5

1

4. ANGX Valuation Analysis

4.1 Price/Earnings Ratio

  • ANGX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ANGX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ANGX Price Earnings VS Forward Price EarningsANGX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ANGX Per share dataANGX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ANGX's earnings are expected to grow with 22.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.16%
EPS Next 3Y22.64%

0

5. ANGX Dividend Analysis

5.1 Amount

  • ANGX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ANGX Fundamentals: All Metrics, Ratios and Statistics

ANGEL STUDIOS INC

NYSE:ANGX (4/27/2026, 11:55:34 AM)

2.6229

+0.1 (+4.08%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)03-12
Earnings (Next)04-30
Inst Owners32.05%
Inst Owner ChangeN/A
Ins Owners5.47%
Ins Owner Change0.56%
Market Cap481.04M
Revenue(TTM)321.56M
Net Income(TTM)-170.48M
Analysts83.33
Price Target7.99 (204.62%)
Short Float %4.56%
Short Ratio4.54
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-49.11%
Min EPS beat(2)-103.96%
Max EPS beat(2)5.73%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.31%
Min Revenue beat(2)4.81%
Max Revenue beat(2)13.82%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-21.67%
PT rev (3m)-24.19%
EPS NQ rev (1m)10.18%
EPS NQ rev (3m)7.78%
EPS NY rev (1m)12.83%
EPS NY rev (3m)25.08%
Revenue NQ rev (1m)2.43%
Revenue NQ rev (3m)14.49%
Revenue NY rev (1m)0.72%
Revenue NY rev (3m)11.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.5
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.23
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.45
OCFYN/A
SpS1.75
BVpS-0.17
TBVpS-0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -70.62%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.17%
FCFM N/A
ROA(3y)-45.42%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.56%
GM growth 5YN/A
F-Score4
Asset Turnover1.33
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 84.67%
Cap/Sales 3.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.62
Quick Ratio 0.61
Altman-Z -1.58
F-Score4
WACC9.52%
ROIC/WACCN/A
Cap/Depr(3y)94.27%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.94%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.58%
EPS Next Y72.4%
EPS Next 2Y35.16%
EPS Next 3Y22.64%
EPS Next 5YN/A
Revenue 1Y (TTM)233.16%
Revenue growth 3Y62.08%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year50.47%
Revenue Next 2Y37.59%
Revenue Next 3Y35.8%
Revenue Next 5YN/A
EBIT growth 1Y-102.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year71.63%
EBIT Next 3Y27.57%
EBIT Next 5YN/A
FCF growth 1Y-57.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38.35%
OCF growth 3YN/A
OCF growth 5YN/A

ANGEL STUDIOS INC / ANGX Fundamental Analysis FAQ

What is the fundamental rating for ANGX stock?

ChartMill assigns a fundamental rating of 2 / 10 to ANGX.


Can you provide the valuation status for ANGEL STUDIOS INC?

ChartMill assigns a valuation rating of 1 / 10 to ANGEL STUDIOS INC (ANGX). This can be considered as Overvalued.


How profitable is ANGEL STUDIOS INC (ANGX) stock?

ANGEL STUDIOS INC (ANGX) has a profitability rating of 1 / 10.


How financially healthy is ANGEL STUDIOS INC?

The financial health rating of ANGEL STUDIOS INC (ANGX) is 0 / 10.